XML 95 R75.htm IDEA: XBRL DOCUMENT
v3.23.3

Business Combinations (Details) $ / shares in Units, $ in Thousands |  |  | 3 Months Ended | 9 Months Ended |  |
--- | --- | --- | --- | --- | --- | ---
Oct. 08, 2023 shares | Aug. 10, 2023 USD ($) D $ / shares shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2023 USD ($) shares | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) shares | Dec. 31, 2021 shares
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Exchange ratio | shares |  | 0.02471853 |  |  |  |  |
Stock converted, reverse recapitalization (in shares) | shares |  | 21,999,886 |  |  |  |  |
Proceeds from transaction |  | $ 42,854 |  |  |  |  |
Proceeds from MTAC trust account |  | 2,704 |  |  |  |  |
Proceeds from private placement |  | 40,150 |  |  |  |  |
Expenses related to business combination |  | 1,742 |  | $ 1,116 | $ 0 |  |
Proceeds from business combination |  | 36,854 |  | $ 36,854 | $ 0 |  |
Transaction costs incurred |  | 6,069 |  |  |  |  |
Transaction costs paid from proceeds |  | 4,327 |  |  |  |  |
MTAC warrants |  | $ 28,927 |  |  |  |  |
Common stock, shares outstanding (in shares) | shares |  | 26,316,681 | 26,316,681 | 26,316,681 |  | 347,926 | 264,977
Options and RSU's outstanding (in shares) | shares |  | 2,816,224 | 7,500,732 | 7,500,732 |  |  |
Warrants outstanding (in shares) | shares |  | 14,266,605 | 14,266,605 | 14,266,605 |  | 2,871,084 |
Sale of stock (in shares) | shares |  | 4,015,002 |  |  |  |  |
Sale of stock, price per share (in dollars per share) | $ / shares |  | $ 10.00 |  |  |  |  |
Net proceeds on sale of stock |  | $ 40,150 |  |  |  |  |
Derivative instrument, contingent consideration, liability, earnout period | 5 years | 5 years |  |  |  |  |
Warrant liability |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
MTAC warrants |  |  | $ 5,421 | $ 5,421 |  | $ 369 |
Minimum |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout period, threshold trading days | D |  | 20 |  |  |  |  |
Maximum |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout period, threshold consecutive trading days | D |  | 30 |  |  |  |  |
Tranche One |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout shares vesting percentage |  | 25 |  |  |  |  |
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares |  | $ 15.00 |  |  |  |  |
Tranche Two |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout shares vesting percentage |  | 25 |  |  |  |  |
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares |  | $ 20.00 |  |  |  |  |
Tranche Three |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout shares vesting percentage |  | 25 |  |  |  |  |
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares |  | $ 25.00 |  |  |  |  |
Tranche Four |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Earnout shares vesting percentage |  | 25 |  |  |  |  |
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares |  | $ 30.00 |  |  |  |  |
MedTech Acquisition Corporation |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Expenses related to business combination |  | $ 6,000 |  |  |  |  |
MTAC Warrants |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
MTAC warrants |  | $ 2,568 |  |  |  |  |
Loss on change in fair value |  |  | $ 2,853 |  |  |  |
Gain on change in fair value |  |  |  | $ 660 |  |  |
Contingent earnout liability |  |  |  |  |  |  |
Reverse Recapitalization [Line Items] |  |  |  |  |  |  |
Shares unvested (in shares) | shares | 3,125,000 | 3,125,000 |  |  |  |  |

X
- Definition Derivative Instrument, Contingent Consideration, Liability, Earnout Period + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod
Namespace Prefix: | tlsi_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger
Namespace Prefix: | tlsi_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdConsecutiveTradingDays
Namespace Prefix: | tlsi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays
Namespace Prefix: | tlsi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodVestingPercentage
Namespace Prefix: | tlsi_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of Shares Unvested + References No definition available. + Details
Name: | tlsi_DerivativeInstrumentContingentConsiderationLiabilityShares
Namespace Prefix: | tlsi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments Of Reverse Recapitalization, Transaction Costs + References No definition available. + Details
Name: | tlsi_PaymentsOfReverseRecapitalizationTransactionCosts
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Proceeds From Reverse Recapitalization + References No definition available. + Details
Name: | tlsi_ProceedsFromReverseRecapitalization
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proceeds From Reverse Recapitalization Transaction + References No definition available. + Details
Name: | tlsi_ProceedsFromReverseRecapitalizationTransaction
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Recapitalization Exchange Ratio + References No definition available. + Details
Name: | tlsi_RecapitalizationExchangeRatio
Namespace Prefix: | tlsi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Reverse Recapitalization + References No definition available. + Details
Name: | tlsi_ReverseRecapitalizationLineItems
Namespace Prefix: | tlsi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Reverse Recapitalization, Transaction Costs Incurred + References No definition available. + Details
Name: | tlsi_ReverseRecapitalizationTransactionCostsIncurred
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Reverse Recapitalization, Transaction Costs Paid + References No definition available. + Details
Name: | tlsi_ReverseRecapitalizationTransactionCostsPaid
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock Converted, Reverse Recapitalization + References No definition available. + Details
Name: | tlsi_StockConvertedReverseRecapitalization
Namespace Prefix: | tlsi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of increase in the fair value of derivatives recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_DerivativeGainOnDerivative
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3 + Details
Name: | us-gaap_DerivativeLiabilitiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of decrease in the fair value of derivatives recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_DerivativeLossOnDerivative
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received by a corporation from a shareholder during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromContributedCapital
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares authorized for issuance under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=tlsi_DerivativeFinancialInstrumentsWarrantLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | tlsi_DerivativeInstrumentPeriodAxis=tlsi_DerivativeInstrumentPeriodOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | tlsi_DerivativeInstrumentPeriodAxis=tlsi_DerivativeInstrumentPeriodTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | tlsi_DerivativeInstrumentPeriodAxis=tlsi_DerivativeInstrumentPeriodThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | tlsi_DerivativeInstrumentPeriodAxis=tlsi_DerivativeInstrumentPeriodFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=tlsi_MedTechAcquisitionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_MTACWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_DerivativeInstrumentContingentEarnoutLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |